ReactTM
Model REACT-68 · Micro Therapeutics, Inc. · DI 00847536031777
DQY — Catheter, Percutaneous · Class II · 21 CFR 870.1250
NRY — Catheter, Thrombus Retriever · Class II · 21 CFR 870.1250
UDILibrary device dossier · generated 2026-09-12 · sources: FDA GUDID, openFDA (recalls, MAUDE, 510(k)/PMA), FDA Data Dashboard (inspections, compliance actions), 510(k) summary documents.
Recall history (0)
No recalls linked in the loaded window.
Adverse-event reports — MAUDE (10)
Caveat (required reading): MAUDE report counts cannot be used to compute incidence rates or compare device safety. Reporting is incomplete, duplicated, and spikes with publicity; there is no denominator of devices in use. The peer line is a reporting baseline (average device in the same product code), not a risk measure.
Malfunction: 7 · Injury: 2 · Death: 1
| Month | This device (reports) | Product-code average (reports per device) |
|---|---|---|
| 2019-01 | 2 | 2.61 |
| 2019-02 | 1 | 2.09 |
| 2019-03 | 0 | 1.88 |
| 2019-04 | 0 | 2.37 |
| 2019-05 | 1 | 1.84 |
| 2019-06 | 0 | 2.09 |
| 2019-07 | 0 | 2.66 |
| 2019-08 | 0 | 2.26 |
| 2019-09 | 0 | 1.79 |
| 2019-10 | 0 | 2.8 |
| 2019-11 | 0 | 2.11 |
| 2019-12 | 0 | 2.24 |
| 2020-01 | 0 | 2.98 |
| 2020-02 | 0 | 2.51 |
| 2020-03 | 1 | 2.36 |
| 2020-04 | 0 | 2.7 |
| 2020-05 | 0 | 2.4 |
| 2020-06 | 0 | 2.44 |
| 2020-07 | 0 | 3.17 |
| 2020-08 | 0 | 2.44 |
| 2020-09 | 1 | 2.46 |
| 2020-10 | 0 | 3.19 |
| 2020-11 | 0 | 2.57 |
| 2020-12 | 0 | 2.83 |
| 2021-01 | 0 | 2.7 |
| 2021-02 | 0 | 2.66 |
| 2021-03 | 0 | 2.47 |
| 2021-04 | 0 | 2.32 |
| 2021-05 | 0 | 2.83 |
| 2021-06 | 0 | 2.46 |
| 2021-07 | 0 | 2.26 |
| 2021-08 | 0 | 2.57 |
| 2021-09 | 0 | 2.39 |
| 2021-10 | 0 | 2.48 |
| 2021-11 | 0 | 2.39 |
| 2021-12 | 0 | 2.48 |
| 2022-01 | 0 | 2.36 |
| 2022-02 | 0 | 2.44 |
| 2022-03 | 0 | 2.2 |
| 2022-04 | 0 | 2.3 |
| 2022-05 | 0 | 1.91 |
| 2022-06 | 1 | 2.42 |
| 2022-07 | 0 | 2.15 |
| 2022-08 | 1 | 2.29 |
| 2022-09 | 0 | 2.28 |
| 2022-10 | 1 | 2.41 |
| 2022-11 | 1 | 2.04 |
| 2022-12 | 0 | 2.04 |
| 2023-01 | 0 | 1.91 |
| 2023-02 | 0 | 2.11 |
| 2023-03 | 0 | 2.11 |
| 2023-04 | 0 | 2.22 |
| 2023-05 | 0 | 2.01 |
| 2023-06 | 0 | 2.34 |
| 2023-07 | 0 | 2.08 |
| 2023-08 | 0 | 2.06 |
| 2023-09 | 0 | 2 |
| 2023-10 | 0 | 2.37 |
| 2023-11 | 0 | 2.52 |
| 2023-12 | 0 | 2.48 |
| 2024-01 | 0 | 1.93 |
| 2024-02 | 0 | 2.14 |
| 2024-03 | 0 | 1.91 |
| 2024-04 | 0 | 2.09 |
| 2024-05 | 0 | 2.04 |
| 2024-06 | 0 | 2.04 |
| 2024-07 | 0 | 2.08 |
| 2024-08 | 0 | 2.14 |
| 2024-09 | 0 | 2.1 |
| 2024-10 | 0 | 2.35 |
| 2024-11 | 0 | 2.42 |
| 2024-12 | 0 | 2.91 |
| 2025-01 | 0 | 2.75 |
| 2025-02 | 0 | 2.86 |
| 2025-03 | 0 | 2.53 |
| 2025-04 | 0 | 2.57 |
| 2025-05 | 0 | 2.57 |
| 2025-06 | 0 | 3.15 |
| 2025-07 | 0 | 3.09 |
| 2025-08 | 0 | 2.53 |
| 2025-09 | 0 | 2.77 |
| 2025-10 | 0 | 3.2 |
| 2025-11 | 0 | 2.99 |
| 2025-12 | 0 | 3.65 |
| 2026-01 | 0 | 3.28 |
| 2026-02 | 0 | 3.16 |
| 2026-03 | 0 | 3.1 |
| 2026-04 | 0 | 3.14 |
| 2026-05 | 0 | 3.42 |
| 2026-06 | 0 | 3.31 |
Regulatory clearances
- K180705 SESE 2018-07-04 (k number procode)
Predicate lineage
K180705 — cites (transitively): K150107 (d1), K161064 (d1), K172448 (d1), K110055 (d2), K152541 (d2), K090752 (d2), K122756 (d2), K133317 (d2), K160449 (d2), K070970 (d3), K072718 (d3), K142458 (d3), K051758 (d3), K100769 (d3), K113163 (d3), K151623 (d3) — cited as predicate by K182101, K220716
K180715 — cites (transitively): K110055 (d1), K151667 (d1), K070970 (d2), K090335 (d2), K110483 (d2), K114083 (d2), K133177 (d2), K080583 (d3) — cited as predicate by K182097, K183463, K193548, K201690, K210230, K220716, K241177
Lineage extracted from public 510(k) summary text (heuristic).
Manufacturer compliance record — Micro Therapeutics, Inc.
- VAI 2021-09-17 Micro Therapeutics, Inc. · 0 citations
- VAI 2015-07-17 Micro Therapeutics, Inc. · 1 citations
- NAI 2015-03-26 Micro Therapeutics, Inc. · 0 citations
- NAI 2013-03-27 Micro Therapeutics, Inc. · 0 citations
- NAI 2012-01-09 Micro Therapeutics, Inc. · 0 citations